ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,873Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 1448

$515K Total Retail Price of All Prescriptions

Rank: 123 out of 1448

1,222 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 11,343 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,276 1,245 1 2
CARVEDILOL 1,031 994 2 1
ISOSORBIDE DINITRATE 814 793 10 3 63
CLOPIDOGREL 586 544 4 10
ISOSORBIDE MONONITRATE ER 583 526 5 16
LOSARTAN POTASSIUM 546 524 6 11
ATENOLOL 531 512 7 12
METOPROLOL SUCCINATE 499 471 8 6
DIOVAN 480 455 9 15
PLAVIX 452 418 10 14
NIFEDIPINE ER 352 340 11 59
PROPRANOLOL HCL 272 260 12 105
AMIODARONE HCL 260 250 13 22
DILTIAZEM 24HR CD 240 227 14 61
LABETALOL HCL 228 228 15 100
PRADAXA 221 220 16 27
LOVAZA 190 169 17 39
CLONIDINE HCL 188 188 18 45
NITROSTAT 176 165 19 31
WARFARIN SODIUM 164 126 20 8
FUROSEMIDE 158 155 21 7
GUANFACINE HCL 128 128 R 22 199
BENAZEPRIL HCL 124 123 23 26
SPIRONOLACTONE 101 99 24 24
METOPROLOL TARTRATE 100 92 25 9
RANEXA 96 95 26 37
SIMVASTATIN 92 69 27 3
DILTIAZEM 24HR ER 89 89 28 52
BENICAR 85 85 29 50
VERAPAMIL ER 80 80 30 88
ATORVASTATIN CALCIUM 79 76 31 4
CILOSTAZOL 75 74 32 95
DILTIAZEM HCL 67 62 33 145
SOTALOL 52 52 34 40
DILTIAZEM ER 50 50 35 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.